Sarah Miksinski
General Counsel at GILEAD SCIENCES, INC.
Sarah Miksinski active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GILEAD SCIENCES, INC. | General Counsel | - | - |
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Director/Board Member | - | - |
Career history of Sarah Miksinski
Former positions of Sarah Miksinski
| Companies | Position | Start | End |
|---|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Statistics
International
| United States | 3 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| General Counsel | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
- Stock Market
- Insiders
- Sarah Miksinski
- Experience
